Latest news

  • February 2026

    Ovesco is now part of the ENGINE Innovation Consortium in Japan!

    The Endeavour for Next Generation of Interventional Endoscopy (ENGINE) project, led by the Department of ...

  • January 2026

    Ovesco has once again been recognized as a Leading Employer in 2026!

    We are pleased to be among Germany’s top 1% of employers, based on a comprehensive ...

  • January 2026

    Ovesco Endoscopy AG invests in Radius Dynamics and supports robotic endoscopy

    Tübingen, January 19, 2025. Ovesco Endoscopy AG, based in Tübingen, is investing in Radius Dynamics ...

  • January 2026

    AWC®duo reduces ESD time and facilitates safe resections

    AWC®duo significantly reduces dissection time in ESD procedures and proves to be a safe and ...

    • Further news at a glance

  • February 2026

    Ovesco is now part of the ENGINE Innovation Consortium in Japan!

    The Endeavour for Next Generation of Interventional Endoscopy (ENGINE) project, led by the Depa ...

  • January 2026

    Ovesco has once again been recognized as a Leading Employer in 2026!

    We are pleased to be among Germany’s top 1% of employers, based on a comprehensive ...

  • January 2026

    Ovesco Endoscopy AG invests in Radius Dynamics and supports robotic endoscopy

    Tübingen, January 19, 2025. Ovesco Endoscopy AG, based in Tübingen, is investing in Radius Dyna ...

  • January 2026

    AWC®duo reduces ESD time and facilitates safe resections

    AWC®duo significantly reduces dissection time in ESD procedures and proves to be a safe and ...

  • December 2025

    Ovesco continues to grow: Groundbreaking for second construction phase in Tübingen

    Tübingen, December 11, 2025 – With a ceremonial groundbreaking, Ovesco Endoscopy AG kicked off ...

  • December 2025

    First U.S. experience with BARS® for anastomotic revision after RYGB

    This case series demonstrates that BARS® enables successful endoscopic gastrojejunal anastomosi ...

  • December 2025

    Ovesco receives award for modern company culture

    Ovesco has been recognized by familyNET 4.0 for our modern und family-friendly company culture! ...

  • November 2025

    Ovesco launches AWC®duo

    The AWC®duo is an innovative product for flexible endoscopy that combines an additional working ...

  • November 2025

    New Indian study: High reliability of FTRD® for gastroduodenal lesions

    gastroduodenal FTRD® demonstrates again its reliability for the treatment of upper GI subepithe ...

  • November 2025

    Ovesco named Financial Times Long-Term Growth Champion for the Second Consecutive Year

    Tuebingen, 13.11.2025. Ovesco Endoscopy AG has been recognized as one of Europe’s Long-Te ...

  • October 2025

    FTRD® effective for duodenal neuroendocrine tumors

    FTRD® for duodenal neuroendocrine tumors (dNETs) shows high technical success as well as R0 res ...

  • October 2025

    Ovesco is FOCUS Leading Innovator 2026

    Ovesco has been named Leading Innovator 2026 by FOCUS Business. Of the approximately 84,000 com ...

  • October 2025

    HemoPill® acute helps to avoid unnecessary emergency endoscopy in patients with high GBS

    HemoPill® acute shows high negative predictive value, highlighting its potential to identify pa ...

  • September 2025

    New Zealand experience adds to FTRD® evidence base

    A New Zealand, multicenter study of 51 cases across the upper and lower GI tract ...

  • September 2025

    Ovesco is part of the SEMECO initiative to develop smart medical devices

    At Ovesco Endoscopy, we are passionate about advancing medical technology to improve patient ou ...

  • September 2025

    Ovesco invests in metabolic-bariatric endoscopy with Trans-Duodenal Concepts

    Tübingen and Mannheim, August 26, 2025. Ovesco Endoscopy AG, based in Tübingen, is investing ne ...

  • July 2025

    Hybrid EMR-FTRD® shows promise for large colonic lesions with suspected cancer

    International study demonstrates high technical success and favorable oncological outcomes for ...

  • July 2025

    BARS® effective for reduction of anastomoses in patients with dumping syndrome

    Anastomotic reduction with BARS® for patients with dumping syndrome is feasible and safe with s ...

  • June 2025

    Efficient and cost-effective: stentfix OTSC® prevents stent migration in FC-SEMS

    Comparison of 316 fully-covered stent placements without fixation, with endoscopic suturing and ...

  • June 2025

    CAES Boston Scientific Innovation Award for BARS® study by Dr. Armin Kuellmer

    PD Dr. Armin Küllmer has received the Boston Scientific Innovation Award from CAES 2025 for ...

  • May 2025

    OTSG Xcavator® effective for removal of large necrotic debris

    OTSG Xcavator® aided the efficient removal of large amounts of necrotic tissue in direct endosc ...

  • April 2025

    Meta-analysis of 5 first-line RCTs: OTSC® effectively reduces rebleeding in NVUGIB

    Meta-analysis of 5 RCTs on OTSC® for the first-line treatment of NVUGIB shows that OTSC® ...

  • April 2025

    ScopeCaps Lead the Way in Innovation

    Innovation is perhaps one of the most overused buzzwords of our time. But for us, ...

  • April 2025

    ArgoCap® wins ESGE Innovation of the Year Award 2025

    At the ESGE Days 2025 in Barcelona, Julius Müller was awarded the Innovation of the ...

  • April 2025

    New study highlights low recurrence rates after colorectal FTRD®

    FTRD® shows low recurrence rates and high success in treating difficult colorectal lesions Key ...

  • April 2025

    OTSC®neo registered in Israel

    With OTSC®neo, we have taken the next step in the development of the OTSC®System. We ...

  • March 2025

    Ovesco Endoscopy AG Partners with NMGN Medical to Improve Endoscopic Foreign Body Removal

    Tuebingen, March 26, 2025. Ovesco Endoscopy AG, a leader in endoluminal surgical procedures, an ...

  • March 2025

    Study highlights HemoPill® acute as a triage tool for reducing inpatient gastroscopies

    UK study on the HemoPill® acute shows that the bleeding-detection capsule could reduce the need ...

  • February 2025

    FTRD® as curative treatment for GI follicular lymphoma of the cecum

    FTRD® enabled R0 resection without complications of an isolated follicular lymphoma in the cecu ...

  • January 2025

    OTSC® System, FTRD® System and remOVE product family approved in Myanmar

    We are pleased to announce that the following products have been successfully registered in Mya ...

  • January 2025

    Ovesco Endoscopy and BioScopeX join forces in developing new tissue biopsy technology

    Tuebingen, Germany, January 2025. Ovesco Endoscopy, Tuebingen, Germany, and BioScopeX, Struer, ...

  • January 2025

    OTSC®neo, BARS® and ArgoCap® approved in Mongolia

    We are pleased to announce that the following products have been approved in Mongolia and ...

  • January 2025

    HemoPill® acute allowed early detection of GI malignancy in 2 cases

    HemoPill® acute allowed the detection of the cause of occult bleeding in comorbid patients with ...

  • December 2024

    OTSC and vacuum therapy combined can allow earlier discharge and lead to better outcomes

    OTSC® closure after endoscopic vacuum therapy (EVT) has the potential to shorten leakage therap ...

  • November 2024

    HemoPill® acute shows high potential as a predictive tool to avoid emergency endoscopies

    HemoPill® acute showed a high negative predictive value for active bleedings and enabled the av ...

  • November 2024

    stentfix OTSC® enables single session EDGE procedure

    stentfix OTSC® System prevents stent migration of LAMS in 100% of cases, enabling a technical ...

  • November 2024

    Ovesco Named Financial Times Long-Term Growth Champion

    Tuebingen, 12.11.2024. Ovesco Endoscopy AG has been recognized as one of Europe’s Long-Te ...

  • October 2024

    Greek Study on Hybrid-FTRD® shows excellent resection rate

    First Greek 2 center experience on Hybrid-FTRD® shows that it enables the treatment of complex ...

  • October 2024

    10 years of FTRD® – Closing the gap between endoscopy and surgery

    The Ovesco FTRD® System is turning 10 years old! FTRD® enables endoscopic full-thickness resect ...

  • October 2024

    Ovesco expands product range in Mexico

    Further Ovesco products are now registered in Mexico and available to users. These include the ...

  • October 2024

    colonic FTRD® and gastroduodenal FTRD® registered in Saudi Arabia

    Both the colonic FTRD® and the gastroduodenal FTRD® have been registered and are now available ...

  • October 2024

    BougieCap shows promising results in EoE Stricture Dilation

    BougieCap enables dilation under visual control in case of eosinophilic esophagitis stricture K ...

  • September 2024

    New Ovesco products available in Kuwait

    We are happy to announce that the following products have been registered and are now ...

  • September 2024

    UK single center study on FTRD® showcases high resection rates

    Largest dataset of 54 cases from a single UK center to date shows high full ...

  • September 2024

    Ovesco begins distribution of products “Assembled in the USA”

    The first products assembled at the Ovesco site in Cary, North Carolina, are now being ...

  • September 2024

    OTSC®neo is now available in Europe

    Ovesco’s first product and the basis for its success was the innovative OTSC® Clip in 2008. ...

  • July 2024

    ArgoCap® approved in Albania

    We are happy to announce that the ArgoCap® has been officially approved in Albania! The ...

  • July 2024

    Ovesco Endoscopy once again recognized as a family-oriented company

    Being able to balance family life and a career is a central aspect for many ...

  • July 2024

    SecureCap as effective tool for removal of food bolus

    remOVE SecureCap proves highly effective in removing food bolus from the esophagus Key findings ...

  • July 2024

    FTRD® meta-analysis: Transforming Colorectal Care

    Meta-analysis of 29 studies shows FTRD® could set new standard for endoscopic treatment in the ...

  • July 2024

    HemoPill monitor: First case of long-term (28 day) use successful

    First application of the HemoPill® monitor capsule for 28 days in patient with fundus variceal ...

  • June 2024

    Listed as Innovation Champion 2024 by FOCUS

    FOCUS-Business has published the list of Innovation Champions 2024, which aims to make particul ...

  • June 2024

    FTRD® case study – successful full-thickness resection via balloon-dilated stoma

    Successful resection of a residual scar in the right colon through a cutaneous stoma with ...

  • May 2024

    BARS case report: potential for non-surgical outlet reduction in post-RYGB weight regain

    BARS® technique successfully used for a minimally invasive revision of post-RYGB weight regain ...

  • May 2024

    International Multicenter Study suggests FTRD could become treatment of choice for dNETs

    Retrospective, international multicenter study on FTRD® for duodenal neuroendocrine tumors reve ...

  • May 2024

    OTSC® – RCT proves OTSC® is superior as first-line treatment in ulcer bleeding

    Multicenter, randomized controlled trial shows higher efficacy of OTSC® in obtaining successful ...

  • April 2024

    ArgoCap® Promising results for facilitation of APC treatment shown by preclinical study

    Preclinical study on feasibility, thermal effects and indication of appropriate settings shows ...

  • April 2024

    Gastroduodenal FTRD® – Case report shows successful resection of accessory spleen

    Successful use of the gastroduodenal FTRD® for diagnostic clarification and resection of an inc ...

  • February 2024

    OTSG Xcavator® approved in South Africa

    We are very proud to announce that our OTSG Xcavator® have received market approval for ...

  • February 2024

    OTSC reduces mortality compared to surgery in refractory ulcer bleeding

    Multicentre comparative study of OTSC versus surgery shows comparable clinical success but lowe ...

  • February 2024

    mini OTSC® System and OTSC® Proctology Anchor approved in Australia

    We are very proud to announce that our products mini OTSC® System and OTSC® Proctology ...

  • February 2024

    remOVE DC Impulse, remOVE DC Cutter Set 12 & Set 14 and FBR Set approved in India

    We are very proud to announce that our products remOVE DC Impulse, remOVE DC Cutter ...

  • January 2024

    HemoPill® and OTSG Xcavator® approved in India

    We are very proud to announce that our products HemoPill® and OTSG Xcavator® have received ...

  • January 2024

    FTRD case study: Successful curing of primary gastric plasmacytoma

    Case study demonstrates successful use of the gastroduodenal FTRD in curing rare primary gastri ...

  • January 2024

    EFTR for small T1CRC: FTRD® shows high R0 resection and low cancer recurrence

    Medium-term outcomes of EFTR for small T1CRC: FTRD® achieves high R0 resection and demonstrates ...

  • December 2023

    Combination therapy of EVT and OTSC® shortens the treatment duration of leaks

    Combination therapy of EVT and OTSC shortens the treatment duration of leaks and enables faster ...

  • December 2023

    colorectal FTRD® in long-term patients: Comparably low rate of recurrent/residual lesions...

    colorectal FTRD® in long-term patients: Rate of recurrent or residual lesions is comparably low ...

  • November 2023

    OTSC® Proctology is a valuable alternative treatment option for complex anal fistulas

    A retrospective study of the use of the OTSC Proctology in 61 patients with complex ...

  • November 2023

    stentfix OTSC® – Study shows successful prevention of FCSEMS migration in the GI tract

    A multicenter experience in 31 patients at high-risk of fully-covered self-expandable metal ste ...

  • October 2023

    gastroduodenal FTRD®: a valuable option for large duodenal neuroendocrine tumors

    EFTR with the gastroduodenal FTRD: a valuable option for the treatment of large duodenal neuroe ...

  • October 2023

    Case report: HemoPill® acute capsule guides timing of enteroscopy

    HemoPill acute capsule guides timing of enteroscopy in a frail patient with multiple comorbidit ...

  • September 2023

    Press release | Worldwide lifesaver

    Worldwide lifesaver with innovative medical technology comes from Tübingen Company among the th ...

  • September 2023

    AWC® offers an affordable and equivalent alternative to double-channel endoscopes

    The additional working channel (AWC) offers an affordable and equivalent alternative to double- ...

  • August 2023

    Hybrid-EFTR – An essential treatment alternative for patients

    Hybrid-EFTR offers an essential treatment alternative for patients with large non-lifting color ...

  • August 2023

    OTSG Xcavator® case report: Successful necrosectomy of an extensive walled-off necrosis

    Use of the OTSG Xcavator in a patient with acute walled-off necrosis showed effective removal ...

  • August 2023

    Ovesco relies on in-house production and literally holds the threads in its hands

    To ensure continued excellent delivery reliability, Ovesco is increasing its own manufacturing ...

  • July 2023

    Review on the FTRD® System – Multi-tasker in the clinical routine

    Due to its high resection rates, low incidence of adverse events and ease of use, ...

  • July 2023

    Recent RCT confirms again that OTSC® is superior to standard therapy

    Recent RCT confirms again that OTSC® is superior to standard therapy in the first-line treatmen ...

  • June 2023

    OTSC® for stent fixation shows significantly lower risk of migration

    Stent fixation: Systematic review shows significantly lower risk of migration and high clinical ...

  • June 2023

    FTRD® System in T1 colorectal cancer

    FTRD® System in T1 colorectal cancer: a potential treatment alternative to surgery In a retrosp ...

  • June 2023

    Ovesco ist Leading Employer 2023

    We, Ovesco Endoscopy AG, have once again been awarded the employer seal „Leading Employer“. Thi ...

  • May 2023

    BougieCap case report: Successful dilation of a duodenal stricture

    Case report: Successful dilation of a duodenal stricture in a 75-year-old cancer patient with t ...

  • May 2023

    Ovesco acquires Belgian-Luxemburg business from Fides Medical

    Tuebingen /Geetbets, 22.05.2023: Ovesco Endoscopy AG takes over the distribution of its product ...

  • May 2023

    Hybrid FTRD case series: Promising results for patients with invasive tumors

    First prospective series of patients with invasive tumors to be treated with hybrid pEMR-EFTR r ...

  • April 2023

    Congress of ESGE 2023 – Congress Report

    Congress Report of the European Society of Gastrointestinal Endoscopy (ESGE) 2023:  OTSC® Syste ...

  • April 2023

    FTRD® is safe with low AE rates and zero AE-related mortality

    Comprehensive international study on the description of adverse events (AE) of colorectal EFTR ...

  • March 2023

    CAES honors Dr. Reimer with the Ovesco Award at this year’s DGE-BV in Cologne

    The Surgical Working Group for Endoscopy and Sonography of the German Society for General and ...

  • March 2023

    52nd Congress of the DGE-BV 2023 – Congress Report

    The 52nd Congress of the German Society for Endoscopy and Imaging Techniques (DGE-BV) took plac ...

  • March 2023

    Largest multicenter RCT on OTSC®

    Largest multicenter RCT on OTSC® shows superiority to standard hemostatic therapy and confirms ...

  • February 2023

    FTRD® System | Largest meta-analysis on EFTR

    Endoscopic Full-Thickness Resection: Meta-analysis of 26 studies confirms clinical benefit and ...

  • January 2023

    Prophylactic appendiceal retrograde intraluminal stent placement “PARIS”

    Supporting the EFTR procedure to reduce appendicitis – Prophylactic appendiceal retrograd ...

  • January 2023

    Stent migration in FC-SEMS – stentfix OTSC® superior to fixation by suturing

    stentfix OTSC shows promising results in terms of migration rate, clinical success, and adverse ...

  • January 2023

    kununu-Siegel „Top Company 2023“

    We, Ovesco Endoscopy AG, have been awarded the kununu seal “Top Company 2023”. we a ...

  • November 2022

    DGVS 2022 | Congress report

    The joint Annual Meeting of the German Society for Gastroenterology, Digestive and Metabolic Di ...

  • October 2022

    OTSG Xcavator® evaluated in first multicenter study

    Collecting experience from 56 cases, the newly released OTSG Xcavator® was evaluated for techni ...

  • September 2022

    Ovesco Endoscopy successful at the “Großer Preis des Mittelstandes”

    Ovesco Endoscopy successful at the “Großer Preis des Mittelstandes” (Grand Prix of Medium-Sized ...

  • September 2022

    Ovesco is official top partner of the Tübingen Tigers

    We are proud to be the official top partner of the Tübingen Tigers from the ...

  • September 2022

    OTSC® Systematic meta-analysis with 914 patients shows superior clinical outcome in NVUGI...

    Meta-analysis, comprising ten studies, showed that OTSC compared with standard therapy for seve ...

  • September 2022

    AWC®: The novel tool reduces procedural time and increases safety of ESD

    An overview article in “Der Gastroenterologe (the gastroenterologist)” presents the AWC as one ...

  • August 2022

    OTSC® for UGI indications shows clinical success rate of 91.3 % in first-line

    OTSC®: Case series on OTSC application for various upper gastrointestinal indications in an Eas ...

  • July 2022

    ESD+ technique could improve duration and technical feasibility of ESD

    AWC®: ESD+ technique for the resection of 4-cm recurrent rectal intramucosal adenocarcinoma led ...

  • July 2022

    OTSC® System and mini OTSC® System market approval in Brazil

    We are very proud to announce that our products OTSC® System and mini OTSC® System ...

  • July 2022

    OTSC® clinical success of 74.3% in treatment of colorectal anastomotic leaks and fistulae...

    A systematic review evaluating 9 studies with overall 107 patients who underwent closure of ana ...

  • May 2022

    Pediatric OTSC® application achieved 90 % clinical success in various indications

    A study analyzing data of two referral pediatric endoscopy units identified 24 OTSC application ...

  • May 2022

    Ovesco offers high and fast delivery capability

    An internal evaluation of the delivery capability and speed to our German, French and US ...

  • April 2022

    OTSC®| Multicenter RCT published in Gut – STING 2 trial

    Multicenter RCT published in Gut – STING 2 trial on first line hemostasis shows superiority ...

  • April 2022

    stentfix OTSC® | 76.5% relative risk reduction of SEMS migration

    stentfix OTSC®: 76.5% relative risk reduction of SEMS migration associated with utilization of ...

  • April 2022

    Ovesco is Leading Employer 2022

    We, Ovesco Endoscopy AG, have been awarded the employer seal „Leading Employer“. This cross-ind ...

  • March 2022

    OTSC® first-line hemostasis: a comparison to standard therapy

    A comparison study on OTSC® vs standard endoscopic therapy as first-line treatment in ulcers wi ...

  • March 2022

    5 minutes of your time for sick children and the future of digital communication at Ovesco...

    Ovesco is currently working to bring you a more comprehensive offer of digital communication. W ...

  • March 2022

    FTRD® System: EFTR superior to ESD

    A comparison study of patients with colonic neoplastic lesions ≤ 30 mm, who underwent either ...

  • February 2022

    Ovesco is member of the Gastroenterlogy Foundation e.V.

    With our membership in the Gastroenterology Foundation e.V., we support the establishment of en ...

  • February 2022

    HemoPill® acute and HemoPill® monitor
    Promising technologies for blood detection in...

    HemoPill® acute and HemoPill® monitor are promising technologies for the detection of blood/hem ...

  • February 2022

    EMR+: Successful removal of a complex colonic lesion with help of the additional working c...

    A case report describes the successful removal of a 22 mm non-granular laterally spreading acro ...

  • January 2022

    OTSC®: AGA Clinical Practice Update recommends OTSC® and stentfix OTSC®

    The guideline recommends first-line OTSC® therapy for esophageal perforation 1 – 2 cm in size, ...

  • December 2021

    Ovesco Endoscopy helps patients in South Africa

    Ovesco helps patients with gastrointestinal diseases in South Africa with free delivery of inno ...

  • November 2021

    DGVS 2021 – Congress report

    The joint Annual Meeting of the German Society for Gastroenterology, Digestive and Metabolic Di ...

  • November 2021

    UEG Week Virtual 2021 – Congress report

    Two major RCTs investigating the OTSC system in first-line therapy were presented at this year& ...

  • October 2021

    OTSC®: Systematic review confirms 85.2 % clinical success rate and 1 % adverse events in ...

    A systematic review of studies evaluating OTSC application for repair of iatrogenic perforation ...

  • October 2021

    OTSC® vs surgery in scope-induced duodenal perforations: Retrospective comparison study s...

    The retrospective analysis included overall 20 patients with type I duodenal perforation. 8 pat ...

  • September 2021

    Hybrid EMR-FTRD®: In large colorectal lesions with non-lifting areas this hybridtechnique...

    A retrospective cohort study of 17 patients undergoing hybrid EMR-FTRD for large colorectal les ...

  • September 2021

    HemoPill® acute: multicentric retrospective study shows promising results in clinical rou...

    The use of the HemoPill acute demonstrated its ability to reliably detect or exclude bleeding ...

  • August 2021

    FTRD®: hybrid technique combining EMR and EFTR permits resection of large polyps

    65 consecutive patients underwent EFTR of colorectal lesions, either via stand-alone EFTR (lesi ...

  • August 2021

    FTRD®: A multicenter retrospective analysis evaluated the risk of appendicitis after EFTR...

    A multicenter retrospective analysis of 50 patients undergoing EFTR for colonic lesions involvi ...

  • July 2021

    Conference Report of DDW 2021

    Conference report of the Digestive Disease Week (DDW) 2021 The conference of the Digestive Dise ...

  • July 2021

    BougieCap®: significant symptomatic improvement of esophageal strictures achieved by a si...

    A cohort study of 50 patients with symptomatic eosinophilic esophagitis treated with a single d ...

  • July 2021

    HemoPill® acute shows promising results in a non-fasting patient with a mid-gastrointesti...

    Ovesco’s first wireless sensor capsule for detection of upper and middle gastrointestinal ...

  • July 2021

    Change in the Executive and Supervisory Boards of Ovesco Endoscopy AG

    Tuebingen, Germany, June 30th, 2021 – Frank Ramsperger, Chairman of the Supervisory Board of Ov ...

  • June 2021

    June 2021: OTSG Xcavator® – available now

    A new dimension in endoscopic grasping: the OTSG Xcavator® The removal of hard to grasp ...

  • May 2021

    50th Anniversary Congress of the DGE-BV 2021 – Congress Report

    The 50th Congress of the German Society for Endoscopy and Imaging Techniques e.V. (DGE-BV) took ...

  • May 2021

    Symposium report DGE-BV 2021 – Part 3
    HemoPill® & OTSC®: telemetric hemo...

    Preliminary results from RCT study show that OTSC first-line treatment is superior to standard ...

  • May 2021

    Symposium report DGE-BV 2021 – Part 2
    HemoPill® & OTSC®: telemetric hemo...

    OTSC® is recommended in current guidelines for the first-line treatment of large ulcers and the ...

  • May 2021

    Ovesco has received the “Innovative through Research” seal of quality

    Based on an R&D data survey by the Stifterverband, Ovesco has qualified to receive the ...

  • May 2021

    Symposium report DGE-BV 2021 – Part 1
    HemoPill® & OTSC®: telemetric hemo...

    The 50th Conference of the German Society for Endoscopy and Imaging Procedures (DGE-BV) took pl ...

  • April 2021

    FTRD®: international study shows favorable safety profile and efficacy of EFTR in the upp...

    FTRD application in 56 patients with lesions in the upper GI tract showed a technical ...

  • April 2021

    EndoAIMS Hands-On Training, April 8, 2021

    We are represented at the EndoAIMS Hands-On Training, April 8, 2021. It is a great ...

  • April 2021

    EndoDigital – Digitalization of user trainings and experimental activities at Ovesco...

    Ovesco Endoscopy AG seizes new opportunities through digital transformation for its workflow in ...

  • March 2021

    Ovesco HemoPill® acute was presented at the International Endoscopy Symposium

    HemoPill® acute for gastrointestinal diagnosis and its future clinical routine – an Interview ( ...

  • March 2021

    Highlights from our webinar “Turn Challenges Into Success Stories” – now available

    We are honored to present the highlights (17 mins) of our webinar “Turn Challenges Into ...

  • March 2021

    OTSC®: Systematic review of 3025 patients demonstrates efficacy in GI hemorrhage, perfora...

    A systematic review of studies with at least five patients examinating OTSC application for any ...

  • March 2021

    Analysis of large nationwide FTRD® registry shows 80 % R0-resection rate of difficult ade...

    Evaluation of the “German colonic FTRD registry” comprising 1178 colorectal FTRD procedures fro ...

  • February 2021

    EFTR with the FTRD® System offers alternative to radical surgery for smaller complex colo...

    A prospective multicenter study analyzing the data of the Dutch colorectal eFTR registry compri ...

  • February 2021

    OTSC® placement in the colon in routine endoscopy: administrative data from large health ...

    Colonic OTSC placement was mostly performed in patients undergoing polypectomy (62.4 %), but al ...

  • January 2021

    OTSC® in first-line treatment of NVUGIB: RCT shows significant benefits of OTSC in rates ...

    53 patients with NVUGIB were randomized to OTSC hemostasis or standard endoscopic treatment. Re ...

  • January 2021

    Turn challenges into success stories – Webinar on Friday 22. January 2021, 10 &#823...

    Insights from 10 speakers and best practice example of empowering high potentials We are honour ...

  • January 2021

    Market approval for LiftUp® in Saudi Arabia

    Ovesco is proud to announce that LiftUp® has received market approval in Saudi Arabia. It ...

  • January 2021

    Coag Dissector: preclinical evaluation of Cold-ESD shows that electrocautery-free dissecti...

    Cold-Endoscopic Submucosal Dissection (C-ESD) was performed in live porcine models. 12 C-ESDs w ...

  • December 2020

    Ovesco HemoPill® acute shows promising results in emergency upper GI hemorrhage diagnosti...

    Ovesco’s first wireless sensor capsule for detection of upper and middle gastrointestinal ...

  • December 2020

    Conference of UEGW 2020

    Conference Report of the United European Gastroenterology Week (UEGW) 2020: HemoPill® acute det ...

  • December 2020

    OTSC® superior to TAE in refractory peptic ulcer bleeding – study shows significantly l...

    Compared to patients treated with transcatheter arterial embolization (TAE) for refractory pept ...

  • November 2020

    Conference of DGVS and DGAV 2020

    Conference of the German Society of Gastroenterology, and Digestive and Metabolic Diseases with ...

  • November 2020

    EMR+: pilot study evaluating data from the first in human clinical cases shows 100 % R0-re...

    The novel EMR+ technique uses an external additional working channel (AWC®) allowing for tissue ...

  • October 2020

    OTSC® closure of the entry site in POEM and G-POEM procedures is related to less clip-rel...

    In 46 POEM and 26 G-POEM procedures, OTSC closure of the entry site was related ...

  • October 2020

    ESD+: preclinical evaluation of the novel technique for endoscopic en-bloc resection shows...

    The novel ESD+ technique uses the external additional working channel (AWC®), which allows for ...

  • October 2020

    Market approval for colonic and diagnostic FTRD® in Brazil

    Ovesco is proud to announce that the colonic and diagnostic FTRD® have received market approval ...

  • October 2020

    2020 Latest ESGE Position Statement on diagnosis and management of iatrogenic endoscopic p...

    OTSC application is recommended for esophageal iatrogenic perforation > 10 mm, for gastric i ...

  • September 2020

    Ovesco Endoscopy funded 555 endoscopies in India for people in need

    In the context of the DGVS 2019 we have started our donation project to provide ...

  • September 2020

    EFTR with the FTRD® should be considered as an alternative to surgery in gastrointestinal...

    A meta-analysis comprising 18 studies with overall 730 patients with difficult gastrointestinal ...

  • September 2020

    OTSC® clipping for recurrent peptic ulcer bleeding is cost-effective as compared to a rep...

    A cost analysis based on mathematic modelling determined the average cost of repeating standard ...

  • August 2020

    Ovesco Endoscopy awarded TOP 10 MEDICAL DIAGNOSTICS Solution Providers 2020

    Ovesco Endoscopy awarded TOP 10 MEDICAL DIAGNOSTICS Solution Providers 2020 Ovesco Endoscopy ha ...

  • August 2020

    Prof. Meining received the ESGE Innovation of the Year 2020 Award for the OTSG Xcavator

    Prof. Alexander Meining, Interventional and Experimental Endoscopy (InExEn), Internal Medicine ...

  • July 2020

    Webinar: Resection techniques in endoluminal surgery – now available online

    Expand your horizon on resection techniques in endoluminal surgery. This was the underlying top ...

  • July 2020

    stentfix OTSC® System: case series shows the new stentfix device to prevent effectively e...

    stentfix OTSC was used in five complex cases who already had experienced stent migration and ...

  • July 2020

    OTSC® management of non-acute full-thickness gastrointestinal defects represents an effec...

    92 patients with 117 non-acute full-thickness gastrointestinal defects (65 fistulas, 52 leaks) ...

  • July 2020

    Live webinar on endoscopy campus

    Resection techniques in endoluminal surgery July 15th, 2020, 4 – 5.30 pm CET Expand your ...

  • June 2020

    First clinical cases with LiftUp® reveal promising results, proving it as valuable, safe ...

    The novel submucosal injection agent LiftUp was successfully used in a first clinical case seri ...

  • June 2020

    BougieCap: case study of post-esophagectomy stricture in the high cervical esophagus succe...

    The patient had experienced esophageal perforation due to bougienage with a through-the-scope b ...

  • June 2020

    FDA clearance for gastroduodenal FTRD®

    Ovesco is proud to announce that the gastroduodenal FTRD® has been cleared for marketing by ...

  • June 2020

    Conference Report of DDW 2020

    Conference report of the Digestive Disease Week (DDW) 2020 FTRD® System: EFTR enables new thera ...

  • May 2020

    OTSC®: 100 % clinical success rate without any complications in patients with perforated ...

    106 patients with perforated peptic ulcer were treated with OTSC (n = 26) or conservative ...

  • May 2020

    Ovesco FTRD® is recommended in the “ASGE guideline for endoscopic full-thickness resect...

    The document reviews current techniques and devices used for EFTR, clinical applications and ou ...

  • April 2020

    OTSC® Proctology: rectovaginal fistula repair with the OTSC Proctology System is feasible...

    16 patients with rectovaginal fistulas, 13 of those having undergone previous surgical interven ...

  • March 2020

    EMR+ enables a grasp-and-snare technique and consequently facilitates en-bloc resection of...

    In lesions > 2 cm, EMR+ outdoes its advantages: comparative trial demonstrates en-bloc resec ...

  • March 2020

    Market approval for LiftUp® in Australia and New Zealand

    Ovesco is proud to announce that LiftUp® has received market approval in Australia and New ...

  • March 2020

    OTSC® beyond standard use: new pictorial publication which explains the use of OTSC to sa...

    Because of its tissue apposition capabilities and easy en face application, OTSC is used as ...

  • March 2020

    OTSC® is associated with better procedural risk profile when compared to standard surgica...

    In 7/10 patients with enterocutaneous fistula, OTSC application resulted in complete fistula cl ...

  • February 2020

    Conference of ACG 2019

    Conference Report of the American College of Gastroenterology (ACG) 2019: OTSC®: Besides a RCT ...

  • February 2020

    As from now, the sales team of ovesco Endoscopy AG will change over to climate-neutral dri...

    „Everyone is just talking about it – ovesco does it“ – thanks to ARKTIK, climate-neutral ...

  • January 2020

    EFTR is a fast, safe and effective option for rectal NETs

    In 40 patients with rectal neuroendocrine tumors (NETs), EFTR resulted in 100 % macroscopically ...

  • January 2020

    Systematic review and meta-analysis of OTSC® therapy for digestive bleeding, covering 851...

    In 851 patients from 21 studies, definitive hemostasis was reached in 87.8 %, technical success ...

  • January 2020

    Ovesco Endoscopy awarded FOCUS Growth Champion 2020

    Ovesco has been able to achieve a large growth in turnover and employees in recent ...

  • January 2020

    Taking the fear out of gastroscopy – the aim of the KMU-innovativ research project ̵...

    Within the scope of the joint research project ‘nuEndo’, Ovesco Endoscopy AG is wor ...

  • January 2020

    The OTSC Proctology® is a safe, effective, minimally invasive, and sphincter-sparing inst...

    In 96 patients with complex anorectal fistulas, OTSC Proctology application lead to an overall ...

  • October 2019

    Market approval for LiftUp® in Australia and New Zealand

    Ovesco is proud to announce that LiftUp® has received market approval in Australia and New ...

  • February 2020

    As from now, the sales team of ovesco Endoscopy AG will change over to climate-neutral dri...

    „Everyone is just talking about it – ovesco does it“ – thanks to ARKTIK, climate-neutral ...

  • December 2019

    Conference of UEGW 2019

    Conference Report of the United European Gastroenterology Week (UEGW) 2019: OTSC® shows superio ...

  • December 2019

    New randomized-controlled trial: OTSC® in first line has superior ability to reduce reble...

    A randomized controlled trial presented at the American College of Gastroenterology (ACG) meeti ...

  • December 2019

    Conference of DGVS and DGAV 2019

    Conference of the German Society of Gastroenterology, and Digestive and Metabolic Diseases with ...

  • November 2019

    Successful closing of WiBEC, a Horizon 2020 Innovative Training Network Project

    Ovesco Endoscopy AG partnered in an innovative training network focusing on “Wireless in-body e ...

  • November 2019

    EFTR is a useful tool for staging of early colorectal cancer and simultaneously can be suf...

    In 156 patients with histologic evidence of adenocarcinoma, EFTR was technically successful in ...

  • November 2019

    FDA approval for stentfix OTSC® System Set

    Ovesco Endoscopy is pleased to announce that the stentfix OTSC® System Set has received market ...

  • November 2019

    Resection techniques EFTR, EMR and ESD chosen as one of the top 3 endoscopic advances of 2...

    The Gastrointestinal Endoscopy Editorial Board chooses resection techniques namely EMR/submucos ...

  • October 2019

    The FTRD® System is a useful tool for R0 resection of complex recurrent / residual colore...

    EFTR in 30 patients with recurrent / residual colorectal neoplasia led to R0 resection in ...

  • October 2019

    Ovesco Endoscopy opens new company headquarters in the Tuebingen Technology Park

    The medical technology company located in Tuebingen will officially inaugurate its new building ...

  • October 2019

    EMR+: preclinical evaluation of the novel technique for endoscopic en-bloc resection prove...

    The novel EMR+ technique uses an external additional working channel (AWC®) and a poloxamer age ...

  • October 2019

    Ovesco Endoscopy AG donates € 3,314.05 to “Help for Sick Children”

    Ovesco Endoscopy AG donates € 3,314.05 to “Help for Sick Children”, the charity at the Tübingen ...

  • September 2019

    OTSC® Proctology: Pilot RCT shows efficacy and safety in achieving permanent closure of c...

    When compared to fistulectomy and primary sphincter reconstruction, the OTSC Proctology showed ...

  • September 2019

    Ovesco`s donation project at the DGVS 2019 in Wiesbaden: “555 Endoscopies for India”

    To err is human – to help is, too! Due to a missed exhibition stand ...

  • September 2019

    The BougieCap provides visual control for effective and safe dilation of esophageal strict...

    In 50 patients with complex benign esophageal stenoses, endoscopic bougienage with the BougieCa ...

  • September 2019

    Ovesco Endoscopy ranks among Germany’s innovation leaders

    For Ovesco Endoscopy AG, product innovation is among their core competences. Within the framewo ...

  • August 2019

    gastroduodenal FTRD®: Full-thickness resection of gastric SETs enables definitive histolo...

    Gastric EFTR in 29 patients with gastric SET led to en-bloc resection in 89.7 %, ...

  • August 2019

    Conference Report of the Digestive Disease Week 2019

    Digestive Disease Week – DDW 2019: – National and international multicenter studies confi ...

  • August 2019

    Family Day and support for the project “Cartoon Drawing” at the University Children...

    On the occasion of the 1st Family Day in the new building, the ovesco Endoscopy ...

  • August 2019

    Conference Report of the German Coloproctology-Congress 2019

    German Coloproctology-Congress of the German Society for Coloproctology (Deutsche Gesellschaft ...

  • July 2019

    Meta-analysis comprising 475 patients demonstrates success of OTSC® as first and second l...

    93 % primary hemostasis was achieved with primary OTSC therapy (288 patients), 91 % with ...

  • July 2019

    EMR+ achieves significantly higher R0 resection rate and requires significantly lower proc...

    In lesions of 3 cm, EMR+ reaches its best discriminatory power: R0 resection rate of ...

  • June 2019

    FTRD®: Multicenter Italian experience confirms effectiveness and safety of the FTRD for s...

    Technical success (lesion reached and resected) was achieved in 94.4 %. R0 resection was achiev ...

  • June 2019

    Conference of DGE-BV 2019 with FTRD® Lunch Symposium

    Conference of the German Society for Endoscopy and Imaging Procedures (DGE-BV) 2019 together wi ...

  • May 2019

    Ovesco Endoscopy AG relies on solar power in new building

    After moving to its new company headquarters in the Technology Park Tuebingen at the beginning ...

  • May 2019

    Systematic review and meta-analysis of OTSC® literature data covering 1868 patients confi...

    Pooled durable clinical success proportions of OTSC use were 87.5 % in hemorrhage, 81.4 % ...

  • April 2019

    ovesco Endoscopy AG moves to new corporate headquarter

    ovesco Endoscopy AG moved to its new headquarters on April 29, 2019 and will thus ...

  • April 2019

    FTRD® resection in the colorectum ensures local radical excision where other endoscopic t...

    Prospective data from 51 FTRD-procedures shows technical success in 88 % (45/51) and a R0-resec ...

  • April 2019

    First case series with the AWC (Additional Working Channel) shows bimanual instrumentation...

    The AWC was used in 8 patients with GI lesions 17-45 mm (average 35.9 mm) ...

  • March 2019

    Market approval for OTSC® and remOVE in Indonesia

    Ovesco is proud to announce that both the OTSC® System and the remOVE System including ...

  • March 2019

    FTRD® is feasible and safe in T1 early rectal cancer: a case series and video report

    6 consecutive T1-ERC patients underwent FTRD application which resulted in complete endoscopic ...

  • March 2019

    Application of the FTRD® in duodenal lesions is feasible, efficacious and safe

    EFTR of duodenal lesions in 20 patients showed technical success in 17/20 (85.0 %), a ...

  • February 2019

    Large multicenter study with 286 patients confirms safety and efficacy of the OTSC® for h...

    96.4 % hemostasis rate is reported from 286 emergency endoscopies for either upper or lower ...

  • February 2019

    OTSC® is safe and effective in pediatric patients for acute GI bleeding throughout the GI...

    Case series of 11 OTSC applications in 10 pediatric patients shows 100 % technical success ...

  • February 2019

    FTRD® is rated a highly effective, time-sparing and safe alternative to ESD for the treat...

    Italian single-center study of 20 consecutive patients with non-lifting lesions, adenoma recurr ...

  • January 2019

    Ovesco Endoscopy AG merges all business entities in the Americas into its Ovesco Endoscopy...

    Ovesco Endoscopy AG merges all business entities in the Americas into its Ovesco Endoscopy USA ...

  • January 2019

    OTSC®: A meta-analysis of 1517 cases over 9 years confirms its outstanding clinical effec...

    OTSC use in patients with refractory gastrointestinal diseases achieved an overall clinical suc ...

  • January 2019

    Multicentric analysis: OTSC® is highly effective as first- and second-line treatment for ...

    In a multicentric cohort of 100 consecutive patients with mean age 72 y, 51 % ...

  • January 2019

    Press release | Ovesco Endoscopy honored as family-friendly company

    Stuttgart, December 11, 2018 – Three medical technology companies of Tübingen receive the famil ...

  • December 2018

    Significant reduction of rebleeding rates in patients with high-risk NVUGIB by OTSC®

    OTSC use decreased the rebleeding rate in high-risk (RS ≥ 8) patients with statistical signific ...

  • December 2018

    Conference of UEGW 2018

    Conference Report of the United European Gastroenterology Week (UEGW) 2018: RESECT+: additional ...

  • November 2018

    Korean multicenter study confirms efficacy and safety of OTSC® for GI fistulas, leaks and...

    All 19 patients were treated successfully with the OTSC System. In 74 % of cases, ...

  • November 2018

    Visually controlled dilatation with the BougieCap is effective and prevents complications ...

    Multicenter study shows high technical success rate and significant improvement of dysphagia sy ...

  • November 2018

    Conference of DGVS and DGAV 2018

    Conference of the German Society of Gastroenterology, and Digestive and Metabolic Diseases with ...

  • October 2018

    Successful application of OTSC in GI bleeding under antithrombotic/anticoagulant therapy

    100 % primary hemostasis rate and improved management of rebleeding with OTSC® used as first ...

  • October 2018

    FTRD offers endoscopic approach in the management of non-lifting and submucosal colorectal...

    87.9 % R0-resection of non-lifting and submucosal colonic lesions with FTRD® Aepli P et al., ...

  • October 2018

    OTSC safe and effective for treatment of leak at the tip of the “J” ileal pouch

    66.6 % of patients with leaking from the “J” of the tip of an ileo-anal ...

  • September 2018

    Dr Edris Wedi honored for his research on hemostasis with the OTSC Clip

    Dr Wedi received the DGVS endoscopy research award for the FLETRock study, a multi-centric stud ...

  • September 2018

    Clinical experience with the remOVE System, a bipolar cutting device for OTSC® removal

    Bauder M et al., Department of Gastroenterology and Oncology, Ludwigsburg Hospital, Ludwigsburg ...

  • August 2018

    Systematic review: leaks and fistulae after laparoscopic sleeve gastrectomy successfully c...

    A systematic literature review evaluating efficacy and safety of the OTSC System in the managem ...

  • August 2018

    Multicenter experience comparing simple suction and OTSC® Twin Grasper®

    Kobara H and colleagues, Department of Gastroenterology and Neurology, Faculty of Medicine, Kag ...

  • July 2018

    Closure of acute GI defects with OTSC® successful in more than 75 % of patients of an uns...

    Raithel M and colleagues, Department of Medicine II, University Erlangen, Germany presented dat ...

  • July 2018

    Ovesco contributes to climate protection and energy conservation

    As part of the “Tübinger Klimaschutzpakt” the Ovesco Endoscopy AG contributes to climate protec ...

  • July 2018

    Market approval for OTSC® in Singapore

    Ovesco is proud to announce that the OTSC® System including the OTSC® Anchor and the ...

  • July 2018

    Single center experience: OTSC® especially valuable in treating defects of the upper gast...

    Mizrahi I and colleagues, Digestive Disease Institute, Cleveland Clinic Florida, Weston, FL, US ...

  • July 2018

    Large single center experience presented: Establishment of the OTSC clip in daily endoscop...

    Honegger C and colleagues, Division of Gastroenterology and Hepatology, University Hospital Zur ...

  • June 2018

    100 % long-term success with OTSC in acute GI defects, 73 % in chronic defects

    Gianfranco G. et al., Interventional Endoscopy Unit, Hospital Privé des Peupliers, Paris, Franc ...

  • June 2018

    Breaking news: Ovesco OTSC Clip superior to standard hemostatic therapy in randomized-cont...

    OTSC has long been described in the scientific literature as a highly effective device for ...

  • May 2018

    Single-center study confirms safety and efficacy of the FTRD in the colorectum

    Valli and colleagues, Division of Gastroenterology and Hepatology, Zurich University Hospital, ...

  • May 2018

    New distribution partners for Bangladesh, Nepal and Pakistan

    Ovesco welcomes following new distribution partners: Biogene Pharma Limited, a leading distribu ...

  • May 2018

    Conference of DGE-BV

    Conference of the German Society for Endoscopy and Imaging Procedures (DGE-BV) together with th ...

  • May 2018

    ESGE Innovation of the Year 2017 Award for the BougieCap

    Prof Dr Alexander Meining, Department of Interventional and Experimental Endoscopy, University ...

  • May 2018

    Award for the 3-Impact model of ++ zepeda given by the Chilean – Germany Chamber of ...

    Within the scope of the Annual Meeting of the Chilean – Germany Chamber of Commerce ...

  • April 2018

    Diagnosis of amyloidosis with FTRD full-thickness rectal tissue sampling

    A. Braun and H. Dawson, Gastroenterology and Endoscopy, SRO Langenthal, Switzerland and Institu ...

  • April 2018

    100 % hemostasis with OTSC reported for first-line emergency treatment of acute hemorrhage...

    The 48th Conference of the German Society for Endoscopy and Imaging Procedures (Deutsche Gesell ...

  • March 2018

    One step application of OTSC for salvage hemostasis and simultaneous perforation closure

    El Douaihy Y et al., Department of Internal Medicine, Staten Island University Hospital – ...

  • March 2018

    PD Dr. Arthur Schmidt, Ludwigsburg, Germany, honored for WALL RESECT study at GASTRO UPDAT...

    PD Dr Schmidt, Department of Inner Medicine II, Gastroenterology, Hepatology, Endocrinology and ...

  • February 2018

    OTSC prevents re-bleeding in over 70% of high-risk GI bleeding cases

    J Brandler and colleagues, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, ...

  • December 2017

    BougieCap launched by Ovesco

    Ovesco is proud to announce the launch of the BougieCap. A new method for the ...

  • December 2017

    FDA clearance for the remOVE System

    Ovesco announces that the remOVE System has been cleared by the US Food and Drug ...

  • December 2017

    Ovesco’s FTRD System is granted market approval for Mexico

    Ovesco is proud to announce that the FTRD System including FTRD Marking Probe and FTRD ...

  • November 2017

    Press release | Ovesco Endoscopy winner of 2017 innovation prize awarded by state of Baden...

    One of Germany’s first innovation awards, the state innovation award Baden-Württemberg – Dr.-Ru ...

  • November 2017

    Market approval for OTSC in Peru

    Ovesco is proud to announce that OTSC has received market approval in Peru. The product ...

  • November 2017

    96% hemostasis with OTSC as first-line treatment in patients with gastrointestinal bleedin...

    Mangiafico S et al., Azienda Ospedaliero, University of Modena, Italy, presented at the 25th UE ...

  • November 2017

    Recommendation for OTSC as first-line therapy in non-variceal upper gastrointestinal bleed...

    Chan SM and Lau JYW, Prince of Wales Hospital, The Chinese University of Hong Kong, ...

  • October 2017

    Market approval in Taiwan for OTSC

    Ovesco is proud to announce that OTSC has received market approval in Taiwan. The product ...

  • October 2017

    Conference of DGVS and DGAV

    Conference of the German Society of Gastroenterology, and Digestive and Metabolic Diseases with ...

  • October 2017

    New Commercial Director MEA, Australasia

    Devan Kizhakee – new Commercial Director MEA, Australasia Devan Kizhakee Kurichyath has a ...

  • September 2017

    Ovesco donates to children’s gastroenterology project

    In July Ovesco Endoscopy celebrated their groundbreaking ceremony for its new corporate headqua ...

  • September 2017

    Prospective multicenter study confirms efficacy and safety of the FTRD device for difficul...

    Schmidt A, Beyna T, Schumacher B et al., affiliated to different German hospitals (Ludwigsburg, ...

  • August 2017

    Ovesco Endoscopy rated as one of the most innovative German companies

    Business news magazine brand eins rates Ovesco Endoscopy among the most innovative German compa ...

  • July 2017

    Conference of the German Society of Endoscopy (DGE-BV) and “ENDOSKOPIE LIVE”

    Innovative BougieCap and resection method developed in cooperation with Ovesco, randomized cont ...

  • July 2017

    Press release | Ovesco Endoscopy to build corporate headquarters for 120 employees

    Tübingen, July 19, 2017 – Groundbreaking ceremony marks beginning of construction Das Tübinger ...

  • July 2017

    Ovesco publishes OTSC update on research conducted with its OTSC clip in case of hemostasi...

    Ovesco publishes an updated OTSC® update containing further relevant publications on research c ...

  • July 2017

    Ovesco’s FTRD System is granted market approval for Ecuador

    Ovesco is proud to announce that the FTRD System including FTRD Marking Probe and FTRD ...

  • July 2017

    Video case report: OTSC hemostasis in patients with refractory bleeding due to chronic pep...

    Xiao X and Lau JY, Department of Surgery, Chinese University of Hong Kong, Hong Kong, ...

  • July 2017

    Ovesco’s FTRD System is granted market approval for Columbia and Argentina

    Ovesco is proud to announce that the FTRD System including FTRD Marking Probe and FTRD ...

  • July 2017

    Prize for the best poster awarded for UK FTRD Registry Data to Dr. Castro Silva and collea...

    Within the scope of the Annual Meeting of the British Society for Gastroenterology (BSG) from ...

  • June 2017

    80 % success in endoscopic closure of post-surgical gastrointestinal leaks

    R Manta et al., Niguarda-Ca Granda Hospital, Milan, Nuovo S. Agostino Hospital, Modena, Nuovo R ...

  • May 2017

    Symposium Report: DGE-BV and Endoscopy Live Congress in Berlin

    Within the scope of the DGE-BV / Endoscopy Live Congress in Berlin, the afternoon symposium ...

  • May 2017

    Dr. Malay Sharma won the Audiovisual Award

    Dr. Malay Sharma from North India received the audiovisual award for the use of the ...

  • April 2017

    Dr. Arthur Schmidt, Ludwigsburg, Germany, honored for best contribution in category &...

    Dr. Schmidt, Department of Inner Medicine, Gastroenterology, Hemato-Oncology, Diabetology and I ...

  • April 2017

    Ovesco is silver sponsor of Endoscopy Campus

    The internet platform Endoscopy Campus is providing the latest information about endoscopy. Tog ...

  • March 2017

    High-risk GI bleeding: primary hemostasis in first-line OTSC treatment in 95%

    HJ Richter-Schrag and colleagues, Center of Interdisciplinary Gastrointestinal Endoscopy and De ...

    • TOP